Golden handcuffs are the unvested equity, deferred compensation and retention awards that make leaving a company expensive. For pharma and biotech executives, they rarely arrive all at once. They build award by award over years of good performance, until staying is no longer fully voluntary. A useful check is to ask whether you would still choose to stay if none of this compensation were at risk.

Golden handcuffs are the unvested equity, deferred compensation and retention awards that make leaving a company expensive. For pharma and biotech executives, they rarely arrive all at once. They build award by award over years of good performance, until staying is no longer fully voluntary. A useful check is to ask whether you would still choose to stay if none of this compensation were at risk.

Golden handcuffs are the unvested equity, deferred compensation and retention awards that make leaving a company expensive. For pharma and biotech executives, they rarely arrive all at once. They build award by award over years of good performance, until staying is no longer fully voluntary. A useful check is to ask whether you would still choose to stay if none of this compensation were at risk.

Golden handcuffs are the unvested equity, deferred compensation and retention awards that make leaving a company expensive. For pharma and biotech executives, they rarely arrive all at once. They build award by award over years of good performance, until staying is no longer fully voluntary. A useful check is to ask whether you would still choose to stay if none of this compensation were at risk.

Advisor Serving Clients Nationwide from Wayne, Pennsylvania  Kingsview Partners is pleased to spotlight Partner and Wealth Manager Leon Shelton, CFP®, CPWA®, who operates his advisory practice out of Wayne, Pennsylvania, serving clients nationwide. Leon brings a rare blend of scientific training, strategic discipline, and long-view thinking to his work, helping clients navigate complex financial decisions with clarity […]